Etanidazole
Names | |
---|---|
IUPAC name
N-(2-Hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide | |
Identifiers | |
22668-01-5 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL47405 |
ChemSpider | 3161 |
ECHA InfoCard | 100.164.363 |
PubChem | 3276 |
UNII | 30DKA3Q1HL |
| |
| |
Properties | |
C7H10N4O4 | |
Molar mass | 214.18 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Etanidazole is a nitroimidazole drug used for its radiosensitizing properties. Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase.[1] The result is that tissues become more sensitive to the ionizing radiation used in cancer treatment.
See also
- EF5, a related nitroimidazole
- Misonidazole
References
- ↑ Definition of etanidazole, National Cancer Institute Drug Dictionary.
This article is issued from Wikipedia - version of the 7/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.